ADAM
Wearable sensor for clinical and research applications
Company profile
Company profile
Sibel Health is a medical technology company founded by world-leading engineers and scientists with a mission to deliver Better Health Data for All®. The company specializes in wireless vital signs monitoring through advanced wearable sensors designed for clinical care, remote patient monitoring, and clinical trials. Their flagship products include the ANNE® family of sensors (ANNE® Chest, ANNE® Limb, and ANNE® One) and ADAM, along with the DISCOVERY platform for clinical research. These FDA-cleared devices utilize mechano-acoustic sensing and skin-interfaced biosensor technology to provide continuous, real-time monitoring of physiological processes and vital signs. Sibel Health's sensors are specifically engineered for delicate skin, making them particularly suitable for neonatal care, while also serving maternal and adult patient populations. The company has deployed over 5,000 systems across more than 20 countries, monitoring over 15,000 patients worldwide. Their technology addresses critical care areas including neonatal intensive care, maternal health, adult care, hospital-at-home programs, and global health initiatives. Sibel Health is committed to engineering excellence and validates their devices through peer-reviewed publications, working to transform healthcare delivery and improve patient outcomes globally, with particular focus on reaching underserved populations in challenging environments.
Company description Sibel Health official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Embedded · Hybrid deployment with recorded integration context.
Company milestones
Deployment of over 5,000 systems across 20+ countries, monitoring 15,000+ patients. Expansion into maternal monitoring and clinical trials applications.
Partnerships
No partners are currently listed.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Wearable sensor for clinical and research applications
Innovative wearable sensor for continuous cough monitoring
Novel wearable sensor for measuring scratching behaviors in atopic dermatitis
First-in-class wearable for continuous lower-leg edema monitoring
Wireless chest-mounted sensor for vital signs monitoring
Wireless limb-mounted sensor for physiological monitoring
First fully wireless comprehensive maternal-fetal monitoring platform
Wireless vital signs monitoring platform for continuous multi-parameter patient monitoring
FDA-cleared bedside application for comprehensive continuous monitoring
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Science advances · Jul 17, 2026
Patient Perceptions on a Wearable Sensor Technology for Swallowing: A Qualitative Study with Patients with Parkinson's Disease.Dysphagia · Jun 1, 2026
Response to "Skin as a sensor: Integrating biophysical wearables into dermatology".Journal of the American Academy of Dermatology · Apr 1, 2026
Methods to Validate Digital Health Technologies for Dermatology.The Journal of investigative dermatology · Nov 1, 2025
Implementing clinical needs into the development of wearable health-monitoring technology.Nature nanotechnology · Oct 1, 2025
Digital health technology for Parkinson's disease with comprehensive monitoring and artificial intelligence-enabled haptic biofeedback for bulbar dysfunction.Journal of Parkinson's disease · May 1, 2025
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Global deployment scale
Clinical usage
Geographic reach
AI-powered wearable devices used to monitor and reduce nocturnal scratching in patients with mild atopic dermatitis
Demonstrated reduction in nighttime scratching, published in JAMA Dermatology
Implementation of wireless continuous hospital monitoring across multiple hospitals in Denmark's capital region
Deployment of FDA-cleared ANNE One platform with AI-driven analytics and cloud integration
Training researchers on wireless monitoring sensors for clinical trials and health research in low-and-middle income countries
Successful researcher training program implementation
05 · Leadership
Leadership profiles and professional links from the current Company record.
Steve Xu
CEO
06 · Company updates
Recent articles published on Sibel Health's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies providing AI-powered remote patient monitoring solutions, wearable health devices with AI analytics, continuous health tracking, or platforms that monitor patients outside clinical settings. Includes general wellness wearables with AI coaching, respiratory monitoring devices, and connected health platforms that aggregate and analyze physiological data from sensors.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.